If Kevin and Stephanie Ness collect their $15 million asking price for the home on Sunset Blvd., it will be the second time ...

Septerna CEO Jeffrey Finer rang the opening bell on the Nasd | South San Francisco-based Septerna has scored with an upsized ...

ISRO & Department of Biotechnology have come together to conduct a series of biotech experiments in space, some of which are ...

GenSight Biologics is weeks away from running out of money. Again. | GenSight Biologics is weeks away from running out of ...

Research suggests that a compound in pomegranates may rejuvenate our cells, boosting immunity and muscles. Food and cosmetic ...

Septerna's shares rose about 31% in their market debut on Friday, giving the Goldman Sachs-backed biotech firm a valuation of ...

Johnson & Johnson's Tremfya showed significant skin clearance in adults with low BSA moderate plaque psoriasis in the ...

Sanofi's Q3 earnings surged, with a 14.4% increase in income to €4.61 billion, led by Dupixent and new launches. Revenue beat ...

Upcycling ingredients from spent coffee grounds to replace virgin materials like palm oil, Revive Eco's contract with France-based biotech company will see operation taken to industrial scale using ...

Septerna Inc. shares soared as much as 42% in their trading debut after the biotechnology company raised $288 million in an ...

Despite a strong Q2, Merck's stock fell due to concerns over Gardasil and Winrevair. See more on MRK stock and its ...

Astellas' first-in-class CLDN18.2 drug Vyloy has cleared the FDA. After a positive phase 3 readout, Otsuka is targeting an ...